Cleared Special

K212008 - Reveal LINQ Insertable Cardiac Monitor (FDA 510(k) Clearance)

Jul 2021
Decision
24d
Days
Class 2
Risk

K212008 is an FDA 510(k) clearance for the Reveal LINQ Insertable Cardiac Monitor. This device is classified as a Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection) (Class II - Special Controls, product code MXD).

Submitted by Medtronic, Inc. (Mounds View, US). The FDA issued a Cleared decision on July 22, 2021, 24 days after receiving the submission on June 28, 2021.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1025.

Submission Details

510(k) Number K212008 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 2021
Decision Date July 22, 2021
Days to Decision 24 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MXD — Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1025

Similar Devices — MXD Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection)

All 14
Assert-IQ (DM5100)
K253516 · Abbott Medical · Dec 2025
LUX-Dx II Insertable Cardiac Monitor (M302)
K252593 · Boston Scientific Corporation · Sep 2025
LINQ II™ Insertable Cardiac Monitor (ICM)
K240693 · Medtronic, Inc. · Mar 2024
LINQ II Insertable Cardiac Monitor
K233562 · Medtronic, Inc. · Dec 2023
LINQ II™ Insertable Cardiac Monitor (LNQ22)
K233320 · Medtronic, Inc. · Oct 2023
LUX-Dx II (M302)
K231328 · Boston Scientific Corp · Aug 2023